| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 28 | 2023 | 134 | 6.530 |
Why?
|
| Hospitalization | 48 | 2023 | 851 | 6.330 |
Why?
|
| Inpatients | 31 | 2023 | 298 | 5.490 |
Why?
|
| Anemia | 6 | 2023 | 128 | 3.640 |
Why?
|
| Cost-Benefit Analysis | 35 | 2019 | 455 | 3.640 |
Why?
|
| Physician-Patient Relations | 23 | 2023 | 610 | 3.190 |
Why?
|
| Quality of Health Care | 20 | 2022 | 381 | 3.070 |
Why?
|
| Medication Adherence | 6 | 2023 | 129 | 3.010 |
Why?
|
| Internal Medicine | 17 | 2017 | 349 | 2.940 |
Why?
|
| Humans | 295 | 2023 | 86678 | 2.710 |
Why?
|
| Patient Satisfaction | 16 | 2020 | 455 | 2.620 |
Why?
|
| Decision Making | 15 | 2020 | 642 | 2.590 |
Why?
|
| Patient-Centered Care | 15 | 2023 | 203 | 2.580 |
Why?
|
| Continuity of Patient Care | 13 | 2020 | 169 | 2.550 |
Why?
|
| Fatigue | 6 | 2022 | 174 | 2.510 |
Why?
|
| Internship and Residency | 24 | 2023 | 1010 | 2.450 |
Why?
|
| Medicare | 13 | 2023 | 410 | 2.430 |
Why?
|
| United States | 81 | 2023 | 6681 | 2.390 |
Why?
|
| Health Care Costs | 16 | 2019 | 239 | 2.390 |
Why?
|
| Health Status | 13 | 2020 | 360 | 2.330 |
Why?
|
| Health Services Research | 14 | 2015 | 136 | 2.300 |
Why?
|
| Aged | 110 | 2023 | 18423 | 2.290 |
Why?
|
| Patient Discharge | 11 | 2020 | 300 | 2.270 |
Why?
|
| Male | 163 | 2023 | 40988 | 2.260 |
Why?
|
| Erythrocyte Transfusion | 4 | 2023 | 60 | 2.230 |
Why?
|
| Patient Preference | 6 | 2020 | 105 | 2.110 |
Why?
|
| Length of Stay | 19 | 2018 | 704 | 2.100 |
Why?
|
| Communication | 18 | 2019 | 442 | 2.060 |
Why?
|
| Female | 157 | 2023 | 44550 | 2.000 |
Why?
|
| Middle Aged | 113 | 2023 | 25040 | 1.990 |
Why?
|
| Pressure Ulcer | 5 | 2018 | 42 | 1.940 |
Why?
|
| Comparative Effectiveness Research | 8 | 2014 | 53 | 1.860 |
Why?
|
| Personnel Staffing and Scheduling | 7 | 2020 | 93 | 1.740 |
Why?
|
| Pharmacogenetics | 12 | 2022 | 434 | 1.690 |
Why?
|
| Pneumonia | 5 | 2022 | 179 | 1.620 |
Why?
|
| Vitamin D Deficiency | 3 | 2022 | 103 | 1.610 |
Why?
|
| Quality-Adjusted Life Years | 22 | 2018 | 138 | 1.610 |
Why?
|
| Quality Indicators, Health Care | 6 | 2017 | 145 | 1.580 |
Why?
|
| Chicago | 37 | 2022 | 1380 | 1.580 |
Why?
|
| Drug Costs | 4 | 2022 | 62 | 1.560 |
Why?
|
| Health Policy | 12 | 2020 | 180 | 1.510 |
Why?
|
| Patient Participation | 8 | 2021 | 216 | 1.440 |
Why?
|
| Efficiency, Organizational | 5 | 2019 | 58 | 1.420 |
Why?
|
| Costs and Cost Analysis | 6 | 2018 | 153 | 1.410 |
Why?
|
| Cost of Illness | 11 | 2018 | 150 | 1.410 |
Why?
|
| Vitamin D | 4 | 2023 | 261 | 1.390 |
Why?
|
| Practice Patterns, Physicians' | 13 | 2019 | 584 | 1.370 |
Why?
|
| Adult | 79 | 2023 | 25659 | 1.320 |
Why?
|
| Community-Acquired Infections | 5 | 2022 | 63 | 1.310 |
Why?
|
| Hospital Costs | 8 | 2018 | 107 | 1.310 |
Why?
|
| Health Expenditures | 7 | 2011 | 86 | 1.290 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2017 | 230 | 1.280 |
Why?
|
| Patient Care Team | 7 | 2016 | 280 | 1.280 |
Why?
|
| Health Priorities | 5 | 2014 | 23 | 1.270 |
Why?
|
| Safety Management | 5 | 2013 | 56 | 1.250 |
Why?
|
| Delivery of Health Care | 7 | 2021 | 426 | 1.240 |
Why?
|
| Medical Staff, Hospital | 10 | 2017 | 107 | 1.210 |
Why?
|
| Quality of Life | 14 | 2018 | 1585 | 1.210 |
Why?
|
| Prostatic Neoplasms | 11 | 2011 | 1721 | 1.170 |
Why?
|
| Academic Medical Centers | 15 | 2019 | 380 | 1.150 |
Why?
|
| Surveys and Questionnaires | 28 | 2021 | 2504 | 1.140 |
Why?
|
| Aged, 80 and over | 40 | 2020 | 6513 | 1.130 |
Why?
|
| Physicians, Primary Care | 6 | 2021 | 104 | 1.110 |
Why?
|
| Geriatrics | 4 | 2015 | 61 | 1.110 |
Why?
|
| Health Care Reform | 4 | 2020 | 90 | 1.110 |
Why?
|
| Urology | 3 | 2023 | 110 | 1.100 |
Why?
|
| Hospitals | 9 | 2022 | 294 | 1.100 |
Why?
|
| Primary Health Care | 7 | 2020 | 339 | 1.100 |
Why?
|
| Attitude of Health Personnel | 10 | 2019 | 636 | 1.090 |
Why?
|
| Socioeconomic Factors | 16 | 2019 | 567 | 1.070 |
Why?
|
| Decision Support Techniques | 8 | 2018 | 160 | 1.060 |
Why?
|
| Sleep | 9 | 2019 | 444 | 1.050 |
Why?
|
| Hospitals, Teaching | 10 | 2015 | 116 | 1.050 |
Why?
|
| Risk Assessment | 18 | 2021 | 2264 | 1.050 |
Why?
|
| Quality Assurance, Health Care | 6 | 2010 | 220 | 1.050 |
Why?
|
| Patient Handoff | 2 | 2017 | 93 | 1.050 |
Why?
|
| Logistic Models | 15 | 2023 | 1188 | 1.040 |
Why?
|
| Physicians | 9 | 2023 | 674 | 1.040 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 1.030 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 301 | 1.020 |
Why?
|
| Health Care Rationing | 8 | 2017 | 83 | 1.010 |
Why?
|
| Economics, Hospital | 3 | 2019 | 11 | 0.990 |
Why?
|
| Data Collection | 14 | 2023 | 372 | 0.990 |
Why?
|
| Vulnerable Populations | 3 | 2010 | 76 | 0.990 |
Why?
|
| Dementia | 5 | 2020 | 187 | 0.980 |
Why?
|
| Health Status Indicators | 5 | 2014 | 105 | 0.970 |
Why?
|
| Interprofessional Relations | 5 | 2010 | 121 | 0.960 |
Why?
|
| Hospital Mortality | 7 | 2022 | 350 | 0.960 |
Why?
|
| Mortality | 4 | 2012 | 149 | 0.950 |
Why?
|
| Health Literacy | 7 | 2020 | 70 | 0.950 |
Why?
|
| Hospitals, University | 13 | 2013 | 194 | 0.940 |
Why?
|
| Prospective Studies | 26 | 2023 | 4214 | 0.940 |
Why?
|
| Models, Econometric | 5 | 2009 | 14 | 0.940 |
Why?
|
| Social Support | 5 | 2018 | 193 | 0.920 |
Why?
|
| Patient Readmission | 9 | 2022 | 329 | 0.920 |
Why?
|
| Physicians, Family | 5 | 2010 | 40 | 0.920 |
Why?
|
| Risk Management | 3 | 2009 | 43 | 0.910 |
Why?
|
| Referral and Consultation | 5 | 2023 | 328 | 0.910 |
Why?
|
| Drug Prescriptions | 6 | 2020 | 141 | 0.890 |
Why?
|
| Emergency Service, Hospital | 4 | 2013 | 484 | 0.890 |
Why?
|
| Cohort Studies | 22 | 2021 | 2768 | 0.880 |
Why?
|
| Cross Infection | 3 | 2020 | 141 | 0.880 |
Why?
|
| Interviews as Topic | 13 | 2018 | 319 | 0.870 |
Why?
|
| Electronic Health Records | 8 | 2018 | 320 | 0.860 |
Why?
|
| Comorbidity | 10 | 2021 | 944 | 0.860 |
Why?
|
| Hospitals, Private | 1 | 2022 | 4 | 0.860 |
Why?
|
| Workload | 5 | 2015 | 128 | 0.850 |
Why?
|
| Hypertension | 6 | 2020 | 1142 | 0.850 |
Why?
|
| Intensive Care Units | 7 | 2016 | 374 | 0.840 |
Why?
|
| Hospital Bed Capacity | 2 | 2019 | 20 | 0.840 |
Why?
|
| Insurance, Health | 7 | 2012 | 160 | 0.830 |
Why?
|
| Patient Transfer | 5 | 2014 | 91 | 0.830 |
Why?
|
| Prescription Fees | 2 | 2016 | 10 | 0.830 |
Why?
|
| Family | 4 | 2018 | 311 | 0.820 |
Why?
|
| Cross-Sectional Studies | 18 | 2022 | 1621 | 0.810 |
Why?
|
| Public Health | 5 | 2016 | 129 | 0.800 |
Why?
|
| Physician's Role | 5 | 2017 | 179 | 0.800 |
Why?
|
| Patient Admission | 6 | 2019 | 112 | 0.790 |
Why?
|
| Pandemics | 4 | 2023 | 740 | 0.790 |
Why?
|
| Poverty | 2 | 2016 | 173 | 0.780 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2023 | 134 | 0.780 |
Why?
|
| Retrospective Studies | 32 | 2023 | 8496 | 0.780 |
Why?
|
| Computer Simulation | 3 | 2019 | 1078 | 0.780 |
Why?
|
| Complementary Therapies | 1 | 2021 | 54 | 0.780 |
Why?
|
| Attitude to Health | 9 | 2017 | 220 | 0.770 |
Why?
|
| Nursing Homes | 4 | 2020 | 109 | 0.770 |
Why?
|
| Pharmacogenomic Testing | 6 | 2022 | 97 | 0.760 |
Why?
|
| Quarantine | 1 | 2020 | 8 | 0.740 |
Why?
|
| Risk Factors | 20 | 2020 | 5420 | 0.740 |
Why?
|
| Group Processes | 1 | 2020 | 31 | 0.740 |
Why?
|
| Betacoronavirus | 2 | 2020 | 258 | 0.730 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 150 | 0.730 |
Why?
|
| Physical Examination | 1 | 2021 | 149 | 0.720 |
Why?
|
| Sex Characteristics | 1 | 2022 | 319 | 0.710 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 372 | 0.700 |
Why?
|
| Drug Industry | 3 | 2023 | 54 | 0.700 |
Why?
|
| Decision Support Systems, Management | 1 | 2019 | 2 | 0.700 |
Why?
|
| Clinical Coding | 2 | 2017 | 23 | 0.700 |
Why?
|
| Exercise | 4 | 2020 | 315 | 0.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2016 | 1375 | 0.690 |
Why?
|
| Precision Medicine | 8 | 2022 | 395 | 0.680 |
Why?
|
| Quality Improvement | 5 | 2016 | 429 | 0.670 |
Why?
|
| Aspirin | 2 | 2018 | 156 | 0.660 |
Why?
|
| Prevalence | 10 | 2023 | 1239 | 0.660 |
Why?
|
| Medical Errors | 3 | 2009 | 115 | 0.650 |
Why?
|
| Diabetes Complications | 4 | 2012 | 207 | 0.650 |
Why?
|
| HIV Infections | 3 | 2015 | 772 | 0.650 |
Why?
|
| Friends | 1 | 2018 | 17 | 0.640 |
Why?
|
| Sepsis | 1 | 2022 | 306 | 0.640 |
Why?
|
| Research Support as Topic | 3 | 2012 | 80 | 0.630 |
Why?
|
| Diabetes Mellitus | 5 | 2014 | 806 | 0.620 |
Why?
|
| Hospital Administration | 3 | 2019 | 26 | 0.620 |
Why?
|
| Social Isolation | 1 | 2018 | 67 | 0.610 |
Why?
|
| Sleep Deprivation | 4 | 2019 | 137 | 0.610 |
Why?
|
| Patients' Rooms | 1 | 2017 | 14 | 0.610 |
Why?
|
| Hospices | 1 | 2017 | 7 | 0.610 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.600 |
Why?
|
| Colonic Diseases | 2 | 2017 | 65 | 0.600 |
Why?
|
| Models, Statistical | 9 | 2016 | 575 | 0.590 |
Why?
|
| Chronic Disease | 4 | 2020 | 973 | 0.590 |
Why?
|
| Therapeutics | 1 | 2016 | 12 | 0.590 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 65 | 0.590 |
Why?
|
| Regression Analysis | 7 | 2017 | 596 | 0.580 |
Why?
|
| Job Satisfaction | 2 | 2008 | 73 | 0.580 |
Why?
|
| Tissue and Organ Procurement | 6 | 2016 | 311 | 0.580 |
Why?
|
| Gastroenterologists | 1 | 2017 | 31 | 0.580 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 1037 | 0.580 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 54 | 0.570 |
Why?
|
| Research | 5 | 2019 | 253 | 0.570 |
Why?
|
| Career Choice | 2 | 2009 | 142 | 0.570 |
Why?
|
| Research Design | 8 | 2019 | 594 | 0.570 |
Why?
|
| Social Security | 1 | 2016 | 5 | 0.570 |
Why?
|
| Blood Glucose | 5 | 2016 | 873 | 0.570 |
Why?
|
| Hemoglobins | 3 | 2022 | 179 | 0.550 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 56 | 0.550 |
Why?
|
| Models, Economic | 6 | 2018 | 60 | 0.550 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2017 | 246 | 0.540 |
Why?
|
| Models, Theoretical | 5 | 2011 | 482 | 0.540 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2014 | 103 | 0.540 |
Why?
|
| Financing, Personal | 3 | 2005 | 21 | 0.540 |
Why?
|
| Age Factors | 12 | 2018 | 1852 | 0.540 |
Why?
|
| Acute Disease | 2 | 2015 | 826 | 0.540 |
Why?
|
| Biomedical Research | 4 | 2018 | 376 | 0.530 |
Why?
|
| Ambulatory Care | 3 | 2023 | 181 | 0.530 |
Why?
|
| Health Resources | 2 | 2013 | 76 | 0.530 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 73 | 0.530 |
Why?
|
| Health Services Accessibility | 7 | 2020 | 394 | 0.520 |
Why?
|
| Laryngectomy | 1 | 2015 | 26 | 0.520 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2015 | 37 | 0.520 |
Why?
|
| Work Schedule Tolerance | 4 | 2008 | 36 | 0.520 |
Why?
|
| Colonoscopy | 1 | 2017 | 267 | 0.520 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 30 | 0.520 |
Why?
|
| Anti-Bacterial Agents | 2 | 2015 | 747 | 0.520 |
Why?
|
| Education, Medical, Graduate | 6 | 2017 | 373 | 0.510 |
Why?
|
| Terminal Care | 3 | 2016 | 130 | 0.510 |
Why?
|
| Time Factors | 21 | 2019 | 5214 | 0.500 |
Why?
|
| Coronary Disease | 3 | 2006 | 261 | 0.500 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 89 | 0.500 |
Why?
|
| Self Care | 4 | 2016 | 164 | 0.500 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 71 | 0.500 |
Why?
|
| Constipation | 1 | 2015 | 63 | 0.500 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 2014 | 3 | 0.500 |
Why?
|
| Diffusion of Innovation | 2 | 2012 | 71 | 0.490 |
Why?
|
| Comprehensive Health Care | 1 | 2014 | 13 | 0.490 |
Why?
|
| Hypoglycemic Agents | 2 | 2008 | 378 | 0.490 |
Why?
|
| Health Surveys | 6 | 2013 | 239 | 0.490 |
Why?
|
| Treatment Outcome | 15 | 2020 | 7998 | 0.480 |
Why?
|
| Investments | 2 | 2012 | 6 | 0.480 |
Why?
|
| Drug Therapy | 3 | 2015 | 70 | 0.480 |
Why?
|
| Antipsychotic Agents | 2 | 2009 | 123 | 0.470 |
Why?
|
| Hospital Medicine | 1 | 2014 | 21 | 0.470 |
Why?
|
| Government Regulation | 5 | 2009 | 49 | 0.470 |
Why?
|
| Multivariate Analysis | 10 | 2017 | 1001 | 0.460 |
Why?
|
| Information Services | 1 | 2013 | 23 | 0.460 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 184 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2019 | 508 | 0.450 |
Why?
|
| Upper Gastrointestinal Tract | 2 | 2010 | 10 | 0.450 |
Why?
|
| Heart Arrest | 5 | 2016 | 265 | 0.450 |
Why?
|
| Interdisciplinary Communication | 2 | 2010 | 130 | 0.440 |
Why?
|
| Text Messaging | 1 | 2013 | 27 | 0.440 |
Why?
|
| Qualitative Research | 6 | 2020 | 256 | 0.440 |
Why?
|
| Food Hypersensitivity | 1 | 2013 | 63 | 0.440 |
Why?
|
| International Classification of Diseases | 4 | 2017 | 69 | 0.430 |
Why?
|
| Adolescent | 18 | 2022 | 8984 | 0.430 |
Why?
|
| Caregivers | 2 | 2013 | 151 | 0.430 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 160 | 0.430 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 116 | 0.430 |
Why?
|
| Genomics | 2 | 2019 | 720 | 0.420 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 144 | 0.420 |
Why?
|
| Medication Errors | 2 | 2013 | 39 | 0.420 |
Why?
|
| Advance Directives | 2 | 2012 | 64 | 0.420 |
Why?
|
| Medical Oncology | 2 | 2019 | 359 | 0.420 |
Why?
|
| Incidence | 5 | 2021 | 1578 | 0.420 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2017 | 50 | 0.410 |
Why?
|
| Drug Approval | 3 | 2012 | 62 | 0.410 |
Why?
|
| Teaching | 3 | 2023 | 147 | 0.410 |
Why?
|
| Morbidity | 1 | 2012 | 148 | 0.400 |
Why?
|
| Night Care | 1 | 2011 | 9 | 0.400 |
Why?
|
| Patient Care | 4 | 2023 | 100 | 0.400 |
Why?
|
| Income | 2 | 2010 | 76 | 0.400 |
Why?
|
| Contraceptives, Oral | 3 | 2020 | 46 | 0.400 |
Why?
|
| Clinical Competence | 8 | 2020 | 756 | 0.400 |
Why?
|
| Decision Support Systems, Clinical | 5 | 2019 | 103 | 0.400 |
Why?
|
| Aging | 3 | 2020 | 691 | 0.390 |
Why?
|
| Communication Barriers | 3 | 2010 | 29 | 0.390 |
Why?
|
| Bariatric Surgery | 1 | 2013 | 194 | 0.390 |
Why?
|
| Social Sciences | 2 | 2009 | 5 | 0.390 |
Why?
|
| Malaysia | 2 | 2021 | 12 | 0.380 |
Why?
|
| Health Services Needs and Demand | 3 | 2020 | 102 | 0.380 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 225 | 0.380 |
Why?
|
| Patient Safety | 2 | 2015 | 212 | 0.380 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 1019 | 0.380 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 827 | 0.380 |
Why?
|
| Health Care Sector | 2 | 2009 | 13 | 0.380 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 429 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2011 | 568 | 0.380 |
Why?
|
| Illinois | 8 | 2022 | 462 | 0.380 |
Why?
|
| Risk Adjustment | 3 | 2018 | 39 | 0.380 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 219 | 0.380 |
Why?
|
| Sickness Impact Profile | 1 | 2010 | 27 | 0.370 |
Why?
|
| Mental Health | 2 | 2009 | 162 | 0.370 |
Why?
|
| Patient Education as Topic | 5 | 2017 | 351 | 0.370 |
Why?
|
| Motivation | 2 | 2010 | 288 | 0.370 |
Why?
|
| Nurse Practitioners | 2 | 2020 | 32 | 0.360 |
Why?
|
| Environmental Health | 1 | 2009 | 7 | 0.360 |
Why?
|
| Global Warming | 1 | 2009 | 6 | 0.360 |
Why?
|
| Waiting Lists | 3 | 2013 | 175 | 0.360 |
Why?
|
| Drugs, Generic | 2 | 2020 | 21 | 0.360 |
Why?
|
| Confidentiality | 5 | 2016 | 78 | 0.360 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 33 | 0.360 |
Why?
|
| Self Concept | 1 | 2010 | 133 | 0.350 |
Why?
|
| Personnel, Hospital | 3 | 2020 | 30 | 0.350 |
Why?
|
| Forms and Records Control | 1 | 2009 | 16 | 0.350 |
Why?
|
| Drug Discovery | 1 | 2010 | 103 | 0.350 |
Why?
|
| Decision Trees | 1 | 2009 | 63 | 0.350 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 32 | 0.350 |
Why?
|
| Medication Systems, Hospital | 2 | 2013 | 7 | 0.340 |
Why?
|
| Sexual Partners | 1 | 2010 | 93 | 0.340 |
Why?
|
| Patient Outcome Assessment | 2 | 2023 | 84 | 0.340 |
Why?
|
| Sex Factors | 7 | 2020 | 1055 | 0.340 |
Why?
|
| Students, Medical | 4 | 2012 | 385 | 0.340 |
Why?
|
| Outpatients | 1 | 2009 | 94 | 0.340 |
Why?
|
| Guideline Adherence | 4 | 2018 | 224 | 0.330 |
Why?
|
| Prescription Drugs | 2 | 2019 | 36 | 0.330 |
Why?
|
| Physical Fitness | 1 | 2009 | 51 | 0.330 |
Why?
|
| Perception | 5 | 2015 | 168 | 0.330 |
Why?
|
| Anesthesiology | 2 | 2022 | 157 | 0.330 |
Why?
|
| Safety | 1 | 2009 | 152 | 0.320 |
Why?
|
| Patient Care Planning | 1 | 2008 | 81 | 0.320 |
Why?
|
| Frail Elderly | 2 | 2010 | 71 | 0.320 |
Why?
|
| Life Expectancy | 8 | 2015 | 86 | 0.320 |
Why?
|
| Activities of Daily Living | 3 | 2022 | 204 | 0.320 |
Why?
|
| Dyssomnias | 1 | 2007 | 7 | 0.310 |
Why?
|
| Hygiene | 1 | 2007 | 10 | 0.310 |
Why?
|
| Models, Educational | 4 | 2017 | 50 | 0.310 |
Why?
|
| Neoplasms | 4 | 2019 | 2898 | 0.310 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2008 | 64 | 0.310 |
Why?
|
| Mental Fatigue | 1 | 2007 | 9 | 0.310 |
Why?
|
| Anxiety | 2 | 2011 | 287 | 0.310 |
Why?
|
| Patients | 4 | 2020 | 100 | 0.310 |
Why?
|
| Cooperative Behavior | 4 | 2015 | 175 | 0.300 |
Why?
|
| Residence Characteristics | 3 | 2018 | 197 | 0.300 |
Why?
|
| Anti-HIV Agents | 1 | 2009 | 149 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 1 | 2009 | 131 | 0.290 |
Why?
|
| Personality Inventory | 1 | 2007 | 108 | 0.290 |
Why?
|
| Young Adult | 13 | 2017 | 5980 | 0.290 |
Why?
|
| Prognosis | 6 | 2016 | 3680 | 0.290 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 235 | 0.290 |
Why?
|
| Spirituality | 3 | 2012 | 87 | 0.290 |
Why?
|
| Health Services | 4 | 2018 | 55 | 0.280 |
Why?
|
| Metered Dose Inhalers | 2 | 2017 | 33 | 0.280 |
Why?
|
| Sleep Wake Disorders | 2 | 2019 | 115 | 0.280 |
Why?
|
| Vascular Diseases | 1 | 2007 | 121 | 0.280 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 148 | 0.280 |
Why?
|
| Data Interpretation, Statistical | 3 | 2018 | 297 | 0.280 |
Why?
|
| Severity of Illness Index | 9 | 2018 | 1802 | 0.270 |
Why?
|
| Blood Transfusion | 3 | 2023 | 157 | 0.270 |
Why?
|
| Geriatric Assessment | 5 | 2019 | 166 | 0.270 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 257 | 0.270 |
Why?
|
| Heart Failure | 2 | 2013 | 1204 | 0.270 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 0.270 |
Why?
|
| Heartburn | 1 | 2005 | 9 | 0.270 |
Why?
|
| Access to Information | 3 | 2017 | 27 | 0.270 |
Why?
|
| Medical Order Entry Systems | 2 | 2017 | 25 | 0.270 |
Why?
|
| Educational Status | 4 | 2013 | 190 | 0.260 |
Why?
|
| Marital Status | 2 | 2019 | 40 | 0.260 |
Why?
|
| Self Disclosure | 1 | 2005 | 31 | 0.260 |
Why?
|
| Mass Screening | 3 | 2015 | 619 | 0.260 |
Why?
|
| Nonprescription Drugs | 1 | 2005 | 15 | 0.260 |
Why?
|
| Pain | 3 | 2022 | 391 | 0.260 |
Why?
|
| Family Practice | 4 | 2010 | 84 | 0.260 |
Why?
|
| Antiviral Agents | 2 | 2022 | 512 | 0.260 |
Why?
|
| Machine Learning | 2 | 2018 | 232 | 0.260 |
Why?
|
| Odds Ratio | 6 | 2019 | 680 | 0.250 |
Why?
|
| Critical Care | 2 | 2019 | 370 | 0.250 |
Why?
|
| Information Dissemination | 2 | 2016 | 103 | 0.250 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 161 | 0.250 |
Why?
|
| Clinical Clerkship | 1 | 2006 | 116 | 0.250 |
Why?
|
| Heart Diseases | 1 | 2007 | 290 | 0.250 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 223 | 0.250 |
Why?
|
| Vision Disorders | 2 | 2016 | 75 | 0.250 |
Why?
|
| Perioperative Care | 3 | 2022 | 161 | 0.250 |
Why?
|
| Health Information Exchange | 2 | 2015 | 12 | 0.250 |
Why?
|
| Forecasting | 7 | 2019 | 305 | 0.240 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 364 | 0.240 |
Why?
|
| Pyrimidinones | 1 | 2023 | 36 | 0.230 |
Why?
|
| Vitamins | 2 | 2022 | 81 | 0.230 |
Why?
|
| ROC Curve | 4 | 2016 | 752 | 0.230 |
Why?
|
| Professional Autonomy | 3 | 2014 | 41 | 0.230 |
Why?
|
| Medical Record Linkage | 4 | 2015 | 17 | 0.230 |
Why?
|
| Postoperative Complications | 1 | 2013 | 2207 | 0.230 |
Why?
|
| Cost Control | 3 | 2014 | 44 | 0.230 |
Why?
|
| Transplantation | 1 | 2003 | 39 | 0.220 |
Why?
|
| Religion | 3 | 2012 | 87 | 0.220 |
Why?
|
| Ticlopidine | 1 | 2023 | 25 | 0.220 |
Why?
|
| Health Care Surveys | 3 | 2010 | 278 | 0.220 |
Why?
|
| United Kingdom | 5 | 2019 | 164 | 0.220 |
Why?
|
| Pharmacists | 1 | 2022 | 32 | 0.220 |
Why?
|
| Point-of-Care Systems | 3 | 2019 | 141 | 0.220 |
Why?
|
| Lung Transplantation | 2 | 2016 | 175 | 0.220 |
Why?
|
| Respiration, Artificial | 2 | 2016 | 334 | 0.220 |
Why?
|
| Trust | 2 | 2021 | 95 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 238 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Managed Competition | 1 | 2002 | 2 | 0.210 |
Why?
|
| Drug Labeling | 3 | 2017 | 41 | 0.210 |
Why?
|
| Prospective Payment System | 1 | 2002 | 7 | 0.210 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.210 |
Why?
|
| Mind-Body Therapies | 1 | 2021 | 3 | 0.210 |
Why?
|
| India | 1 | 2022 | 120 | 0.210 |
Why?
|
| Reproducibility of Results | 7 | 2013 | 2706 | 0.200 |
Why?
|
| Documentation | 3 | 2013 | 98 | 0.200 |
Why?
|
| Medicine | 3 | 2016 | 90 | 0.200 |
Why?
|
| Nursing Staff, Hospital | 2 | 2019 | 42 | 0.200 |
Why?
|
| Prostatectomy | 2 | 2005 | 471 | 0.200 |
Why?
|
| Tissue Donors | 2 | 2016 | 464 | 0.200 |
Why?
|
| Self Efficacy | 2 | 2013 | 53 | 0.200 |
Why?
|
| Obesity | 1 | 2008 | 964 | 0.200 |
Why?
|
| Weight Lifting | 1 | 2020 | 7 | 0.200 |
Why?
|
| Asthma | 3 | 2017 | 955 | 0.200 |
Why?
|
| Oral Health | 1 | 2020 | 10 | 0.190 |
Why?
|
| Program Development | 6 | 2017 | 125 | 0.190 |
Why?
|
| Calcifediol | 1 | 2020 | 21 | 0.190 |
Why?
|
| Patient Selection | 4 | 2018 | 686 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2020 | 573 | 0.190 |
Why?
|
| Warfarin | 3 | 2019 | 103 | 0.190 |
Why?
|
| Athletes | 1 | 2020 | 46 | 0.190 |
Why?
|
| Athletic Performance | 1 | 2020 | 31 | 0.190 |
Why?
|
| Value of Life | 1 | 2000 | 22 | 0.190 |
Why?
|
| Symptom Assessment | 1 | 2020 | 65 | 0.190 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2020 | 31 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 2360 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
| Resuscitation Orders | 2 | 2012 | 62 | 0.180 |
Why?
|
| Anesthesia | 1 | 2022 | 164 | 0.180 |
Why?
|
| Learning | 1 | 2003 | 281 | 0.180 |
Why?
|
| Psychometrics | 4 | 2011 | 327 | 0.180 |
Why?
|
| Disease Management | 3 | 2019 | 327 | 0.180 |
Why?
|
| Social Class | 3 | 2013 | 128 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 231 | 0.180 |
Why?
|
| Aftercare | 1 | 2020 | 85 | 0.180 |
Why?
|
| Calcitriol | 1 | 2020 | 174 | 0.180 |
Why?
|
| Life Style | 2 | 2020 | 189 | 0.180 |
Why?
|
| Markov Chains | 2 | 2018 | 125 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2015 | 351 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 383 | 0.170 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 3642 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 293 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 78 | 0.170 |
Why?
|
| Pediatrics | 1 | 2003 | 344 | 0.170 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2018 | 16 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2016 | 840 | 0.170 |
Why?
|
| Radiotherapy | 1 | 2001 | 328 | 0.170 |
Why?
|
| Pharmacogenomic Variants | 1 | 2019 | 41 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2011 | 191 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2022 | 409 | 0.160 |
Why?
|
| Education, Medical, Continuing | 2 | 2010 | 107 | 0.160 |
Why?
|
| Pain Management | 1 | 2019 | 127 | 0.160 |
Why?
|
| Linear Models | 4 | 2016 | 422 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 2357 | 0.160 |
Why?
|
| Telemedicine | 1 | 2020 | 169 | 0.160 |
Why?
|
| Family Health | 2 | 2013 | 162 | 0.150 |
Why?
|
| Biological Products | 1 | 2019 | 143 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 162 | 0.150 |
Why?
|
| Cardiology | 2 | 2011 | 123 | 0.150 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2014 | 6 | 0.150 |
Why?
|
| Social Networking | 1 | 2018 | 75 | 0.150 |
Why?
|
| Insurance Claim Review | 1 | 2017 | 41 | 0.150 |
Why?
|
| Medical Overuse | 1 | 2017 | 36 | 0.150 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 1686 | 0.150 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 69 | 0.150 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 166 | 0.150 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.150 |
Why?
|
| Mitral Valve | 1 | 2018 | 248 | 0.140 |
Why?
|
| Physical Education and Training | 1 | 1996 | 3 | 0.140 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 187 | 0.140 |
Why?
|
| Health Services Misuse | 2 | 2013 | 19 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 199 | 0.140 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2016 | 50 | 0.140 |
Why?
|
| Liver Transplantation | 3 | 2003 | 1271 | 0.140 |
Why?
|
| Vital Signs | 2 | 2016 | 38 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 45 | 0.140 |
Why?
|
| Renal Dialysis | 2 | 2013 | 355 | 0.140 |
Why?
|
| Face | 1 | 2016 | 114 | 0.140 |
Why?
|
| Hospitals, General | 1 | 2015 | 12 | 0.140 |
Why?
|
| Developing Countries | 1 | 2016 | 71 | 0.140 |
Why?
|
| Health Equity | 1 | 2017 | 77 | 0.140 |
Why?
|
| Osteoarthritis, Hip | 1 | 2015 | 23 | 0.130 |
Why?
|
| Child | 7 | 2022 | 6928 | 0.130 |
Why?
|
| Public Policy | 2 | 2010 | 52 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2016 | 176 | 0.130 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.130 |
Why?
|
| Attitude to Death | 2 | 2012 | 36 | 0.130 |
Why?
|
| Schizophrenia | 1 | 1999 | 464 | 0.130 |
Why?
|
| Budgets | 1 | 2014 | 10 | 0.130 |
Why?
|
| Midwestern United States | 3 | 2007 | 76 | 0.130 |
Why?
|
| Monte Carlo Method | 3 | 2007 | 185 | 0.130 |
Why?
|
| Medical Records | 1 | 2015 | 119 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 63 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 2 | 2005 | 20 | 0.130 |
Why?
|
| Program Evaluation | 4 | 2011 | 297 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2015 | 69 | 0.130 |
Why?
|
| Health Behavior | 1 | 1996 | 183 | 0.130 |
Why?
|
| Career Mobility | 2 | 2014 | 31 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 23 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 257 | 0.120 |
Why?
|
| Workplace | 3 | 2012 | 27 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 98 | 0.120 |
Why?
|
| Statistics as Topic | 2 | 2007 | 238 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2012 | 59 | 0.120 |
Why?
|
| Physician Impairment | 1 | 2014 | 6 | 0.120 |
Why?
|
| State Medicine | 2 | 2017 | 12 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 1673 | 0.120 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 126 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 1992 | 0.120 |
Why?
|
| Algorithms | 3 | 2015 | 1830 | 0.120 |
Why?
|
| Genome, Human | 1 | 2019 | 756 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 2 | 2007 | 353 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1961 | 0.120 |
Why?
|
| Meaningful Use | 1 | 2013 | 2 | 0.120 |
Why?
|
| Liver Diseases | 2 | 2014 | 241 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 102 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2015 | 102 | 0.120 |
Why?
|
| Occupational Health | 1 | 2014 | 32 | 0.120 |
Why?
|
| Social Values | 1 | 2013 | 44 | 0.120 |
Why?
|
| Dizziness | 1 | 2013 | 27 | 0.120 |
Why?
|
| Electronic Prescribing | 1 | 2013 | 11 | 0.120 |
Why?
|
| Emergency Treatment | 1 | 2013 | 39 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2015 | 111 | 0.120 |
Why?
|
| Urologists | 2 | 2023 | 24 | 0.110 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Reimbursement Mechanisms | 1 | 2013 | 41 | 0.110 |
Why?
|
| Emergencies | 1 | 2013 | 113 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 2013 | 31 | 0.110 |
Why?
|
| Community Participation | 1 | 2013 | 36 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 225 | 0.110 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2012 | 24 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 327 | 0.110 |
Why?
|
| Names | 1 | 2012 | 10 | 0.110 |
Why?
|
| School Admission Criteria | 1 | 2012 | 23 | 0.110 |
Why?
|
| Language | 1 | 2014 | 151 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2014 | 94 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2013 | 119 | 0.110 |
Why?
|
| Huntington Disease | 1 | 2012 | 37 | 0.110 |
Why?
|
| Specialization | 2 | 2008 | 65 | 0.100 |
Why?
|
| Noise | 1 | 2012 | 27 | 0.100 |
Why?
|
| Treatment Refusal | 1 | 2012 | 60 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2015 | 371 | 0.100 |
Why?
|
| Triage | 1 | 2012 | 108 | 0.100 |
Why?
|
| Competency-Based Education | 2 | 2008 | 35 | 0.100 |
Why?
|
| Military Personnel | 1 | 2012 | 85 | 0.100 |
Why?
|
| Software | 1 | 2015 | 654 | 0.100 |
Why?
|
| Vital Capacity | 1 | 2011 | 64 | 0.100 |
Why?
|
| Computer Security | 3 | 2015 | 16 | 0.100 |
Why?
|
| Psychology, Industrial | 1 | 2010 | 2 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2013 | 226 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2011 | 57 | 0.100 |
Why?
|
| Guidelines as Topic | 3 | 2019 | 162 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 122 | 0.100 |
Why?
|
| Internet | 3 | 2020 | 312 | 0.090 |
Why?
|
| Multilingualism | 1 | 2010 | 10 | 0.090 |
Why?
|
| Education | 1 | 2010 | 58 | 0.090 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2010 | 8 | 0.090 |
Why?
|
| Economics | 1 | 2010 | 11 | 0.090 |
Why?
|
| Age Distribution | 3 | 2012 | 204 | 0.090 |
Why?
|
| Off-Label Use | 1 | 2010 | 16 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2010 | 90 | 0.090 |
Why?
|
| Goals | 1 | 2010 | 67 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 1998 | 938 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2016 | 1538 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2013 | 816 | 0.090 |
Why?
|
| Awareness | 1 | 2010 | 93 | 0.090 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 462 | 0.090 |
Why?
|
| Policy | 1 | 2010 | 34 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 57 | 0.090 |
Why?
|
| Personnel Selection | 1 | 2010 | 59 | 0.090 |
Why?
|
| Policy Making | 2 | 2020 | 62 | 0.090 |
Why?
|
| Physical Therapy Modalities | 2 | 2023 | 84 | 0.090 |
Why?
|
| Environmental Pollution | 1 | 2009 | 13 | 0.090 |
Why?
|
| Cause of Death | 1 | 2010 | 277 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2012 | 1144 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 98 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 71 | 0.090 |
Why?
|
| Leadership | 1 | 2010 | 134 | 0.080 |
Why?
|
| Health Status Disparities | 2 | 2008 | 170 | 0.080 |
Why?
|
| Affect | 1 | 2011 | 386 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 1204 | 0.080 |
Why?
|
| Focus Groups | 2 | 2020 | 155 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 188 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 521 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 153 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2011 | 209 | 0.080 |
Why?
|
| Infant | 2 | 2013 | 3047 | 0.080 |
Why?
|
| Organizations, Nonprofit | 1 | 2008 | 8 | 0.080 |
Why?
|
| Air Pollution | 1 | 2009 | 68 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 27 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2008 | 20 | 0.080 |
Why?
|
| Counseling | 1 | 2010 | 145 | 0.080 |
Why?
|
| Blood Banks | 1 | 2008 | 7 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2013 | 3613 | 0.080 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 4 | 0.080 |
Why?
|
| Medicare Part D | 1 | 2008 | 10 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2008 | 30 | 0.080 |
Why?
|
| Empirical Research | 1 | 2007 | 19 | 0.080 |
Why?
|
| Accreditation | 1 | 2008 | 60 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2009 | 182 | 0.080 |
Why?
|
| Information Storage and Retrieval | 2 | 2021 | 120 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 912 | 0.080 |
Why?
|
| Organ Transplantation | 2 | 2003 | 265 | 0.080 |
Why?
|
| Fetal Blood | 1 | 2008 | 90 | 0.080 |
Why?
|
| Gastroenterology | 1 | 2010 | 140 | 0.080 |
Why?
|
| Uncertainty | 1 | 2008 | 71 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2008 | 58 | 0.080 |
Why?
|
| Hospital Charges | 2 | 2012 | 29 | 0.080 |
Why?
|
| Sick Role | 1 | 2007 | 13 | 0.080 |
Why?
|
| China | 1 | 2008 | 228 | 0.080 |
Why?
|
| Rural Population | 1 | 2008 | 136 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 243 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2010 | 230 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2008 | 228 | 0.070 |
Why?
|
| Delirium | 1 | 2007 | 66 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 93 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2006 | 4 | 0.070 |
Why?
|
| Actigraphy | 2 | 2017 | 51 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 2 | 2003 | 509 | 0.070 |
Why?
|
| Urban Population | 1 | 2008 | 214 | 0.070 |
Why?
|
| Community Health Centers | 1 | 2007 | 113 | 0.070 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 62 | 0.070 |
Why?
|
| Survival Rate | 1 | 2010 | 1864 | 0.070 |
Why?
|
| Biopsy | 2 | 2011 | 1163 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2007 | 303 | 0.070 |
Why?
|
| Administration, Inhalation | 2 | 2017 | 188 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2013 | 1351 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 111 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2007 | 218 | 0.070 |
Why?
|
| Health Education | 1 | 2006 | 101 | 0.070 |
Why?
|
| Diabetic Neuropathies | 1 | 2006 | 40 | 0.070 |
Why?
|
| Bacteria | 1 | 2009 | 447 | 0.070 |
Why?
|
| Self Report | 2 | 2020 | 288 | 0.070 |
Why?
|
| Education, Medical | 1 | 2008 | 234 | 0.070 |
Why?
|
| Bayes Theorem | 1 | 2007 | 361 | 0.070 |
Why?
|
| Consumer Behavior | 1 | 2005 | 29 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 399 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 2006 | 87 | 0.060 |
Why?
|
| Diet | 1 | 2008 | 443 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 865 | 0.060 |
Why?
|
| Geography | 2 | 2016 | 223 | 0.060 |
Why?
|
| Fever of Unknown Origin | 1 | 2003 | 5 | 0.060 |
Why?
|
| Industry | 1 | 2023 | 16 | 0.060 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2003 | 5 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2023 | 58 | 0.060 |
Why?
|
| Hospital Rapid Response Team | 2 | 2014 | 27 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2023 | 7 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 248 | 0.060 |
Why?
|
| Hematuria | 1 | 2023 | 49 | 0.060 |
Why?
|
| Cholecalciferol | 1 | 2022 | 35 | 0.050 |
Why?
|
| Consensus | 2 | 2016 | 336 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Succinylcholine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 20 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
| Proxy | 2 | 2012 | 24 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2022 | 128 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.050 |
Why?
|
| California | 1 | 2002 | 138 | 0.050 |
Why?
|
| Translating | 1 | 2001 | 18 | 0.050 |
Why?
|
| Health Maintenance Organizations | 1 | 2001 | 20 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 83 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2022 | 90 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 133 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 916 | 0.050 |
Why?
|
| Papanicolaou Test | 1 | 2001 | 38 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2013 | 122 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 1852 | 0.050 |
Why?
|
| Blood Pressure Determination | 2 | 2012 | 90 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
| Vaginal Smears | 1 | 2001 | 68 | 0.050 |
Why?
|
| Housing | 1 | 2021 | 42 | 0.050 |
Why?
|
| Social Welfare | 1 | 2001 | 19 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2001 | 62 | 0.050 |
Why?
|
| Professional Competence | 1 | 2001 | 68 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Curriculum | 2 | 2020 | 543 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2011 | 229 | 0.050 |
Why?
|
| Menopause | 1 | 2020 | 71 | 0.050 |
Why?
|
| Insulin | 1 | 2006 | 1160 | 0.050 |
Why?
|
| Virus Replication | 1 | 2022 | 319 | 0.050 |
Why?
|
| Parents | 1 | 2023 | 272 | 0.050 |
Why?
|
| United States Food and Drug Administration | 2 | 2013 | 127 | 0.050 |
Why?
|
| SEER Program | 1 | 2001 | 190 | 0.050 |
Why?
|
| Ethnobotany | 1 | 2019 | 1 | 0.050 |
Why?
|
| Ethics Committees | 1 | 2000 | 8 | 0.050 |
Why?
|
| Ethicists | 1 | 2000 | 20 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 112 | 0.050 |
Why?
|
| Ethics Consultation | 1 | 2000 | 12 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 106 | 0.050 |
Why?
|
| United States Public Health Service | 1 | 1999 | 3 | 0.050 |
Why?
|
| Blindness | 1 | 2000 | 41 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 104 | 0.040 |
Why?
|
| Bias | 1 | 2000 | 127 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 1169 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2000 | 65 | 0.040 |
Why?
|
| Leg | 1 | 2000 | 137 | 0.040 |
Why?
|
| Computational Biology | 1 | 2023 | 528 | 0.040 |
Why?
|
| Drug Recalls | 1 | 2019 | 13 | 0.040 |
Why?
|
| Codeine | 1 | 2019 | 12 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2019 | 19 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1464 | 0.040 |
Why?
|
| Disease | 1 | 1999 | 90 | 0.040 |
Why?
|
| Health Planning | 1 | 2018 | 17 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 456 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2019 | 149 | 0.040 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 47 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2001 | 275 | 0.040 |
Why?
|
| Denmark | 1 | 1998 | 15 | 0.040 |
Why?
|
| Risk | 1 | 2000 | 674 | 0.040 |
Why?
|
| Teaching Materials | 2 | 2008 | 12 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 231 | 0.040 |
Why?
|
| Frailty | 1 | 2019 | 58 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 669 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2000 | 306 | 0.040 |
Why?
|
| Decision Making, Organizational | 1 | 2016 | 6 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 240 | 0.040 |
Why?
|
| Videotape Recording | 1 | 2017 | 47 | 0.040 |
Why?
|
| Self Administration | 1 | 2017 | 73 | 0.040 |
Why?
|
| Negotiating | 1 | 2016 | 19 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2016 | 31 | 0.040 |
Why?
|
| Health Personnel | 1 | 2019 | 202 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2016 | 39 | 0.040 |
Why?
|
| Cost Savings | 2 | 2011 | 67 | 0.040 |
Why?
|
| Faculty, Medical | 2 | 2008 | 179 | 0.040 |
Why?
|
| Self-Management | 1 | 2016 | 29 | 0.040 |
Why?
|
| Social Perception | 1 | 2017 | 95 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2019 | 408 | 0.030 |
Why?
|
| Support Vector Machine | 1 | 2016 | 25 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 90 | 0.030 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2016 | 24 | 0.030 |
Why?
|
| Checklist | 1 | 2016 | 57 | 0.030 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2015 | 6 | 0.030 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 1939 | 0.030 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 153 | 0.030 |
Why?
|
| Accelerometry | 1 | 2015 | 36 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 407 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 28 | 0.030 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2014 | 4 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 177 | 0.030 |
Why?
|
| Empathy | 1 | 2016 | 147 | 0.030 |
Why?
|
| Information Systems | 1 | 2014 | 29 | 0.030 |
Why?
|
| Polysomnography | 1 | 2014 | 151 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 339 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 132 | 0.030 |
Why?
|
| Economics, Medical | 1 | 1993 | 6 | 0.030 |
Why?
|
| Egypt | 1 | 2013 | 13 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 1996 | 324 | 0.030 |
Why?
|
| Efficiency | 1 | 1993 | 40 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 861 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 860 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 54 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2014 | 117 | 0.030 |
Why?
|
| Sick Leave | 1 | 2012 | 13 | 0.030 |
Why?
|
| Military Medicine | 1 | 2012 | 20 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 2380 | 0.030 |
Why?
|
| Patient Credit and Collection | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hemorrhoids | 1 | 1991 | 5 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 173 | 0.030 |
Why?
|
| Anus Diseases | 1 | 1991 | 14 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 1991 | 24 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2012 | 34 | 0.030 |
Why?
|
| Australia | 1 | 2011 | 99 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2012 | 123 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 26590 | 0.020 |
Why?
|
| American Heart Association | 1 | 2011 | 92 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 677 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 136 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 309 | 0.020 |
Why?
|
| Admitting Department, Hospital | 1 | 2010 | 1 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1532 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 2010 | 36 | 0.020 |
Why?
|
| Klebsiella | 1 | 2009 | 6 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 40 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 2010 | 57 | 0.020 |
Why?
|
| Maryland | 1 | 2009 | 35 | 0.020 |
Why?
|
| Pseudomonas | 1 | 2009 | 51 | 0.020 |
Why?
|
| Enterococcus | 1 | 2009 | 35 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 1128 | 0.020 |
Why?
|
| Drug Information Services | 1 | 2008 | 1 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2009 | 34 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 819 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2008 | 14 | 0.020 |
Why?
|
| Community Health Services | 1 | 2010 | 80 | 0.020 |
Why?
|
| Developed Countries | 1 | 2008 | 24 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 27 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 170 | 0.020 |
Why?
|
| Health Promotion | 1 | 2010 | 160 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2008 | 69 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 11356 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2008 | 46 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1807 | 0.020 |
Why?
|
| Psychology, Educational | 1 | 2006 | 2 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2006 | 14 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 674 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 263 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2009 | 597 | 0.020 |
Why?
|
| Intention | 1 | 2006 | 51 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 549 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2008 | 456 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2006 | 157 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2005 | 47 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 168 | 0.020 |
Why?
|
| Canada | 1 | 2003 | 204 | 0.010 |
Why?
|
| New England | 1 | 2001 | 10 | 0.010 |
Why?
|
| Portugal | 1 | 2001 | 21 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2001 | 55 | 0.010 |
Why?
|
| Job Description | 1 | 2000 | 8 | 0.010 |
Why?
|
| Euthanasia, Passive | 1 | 2000 | 16 | 0.010 |
Why?
|
| Medical Futility | 1 | 2000 | 28 | 0.010 |
Why?
|
| Ethics, Clinical | 1 | 2000 | 48 | 0.010 |
Why?
|
| Benchmarking | 1 | 2000 | 79 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 1979 | 7 | 0.010 |
Why?
|
| Hemoptysis | 1 | 1979 | 24 | 0.010 |
Why?
|
| Sweden | 1 | 1997 | 40 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 2379 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 849 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 143 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1979 | 227 | 0.010 |
Why?
|
| Barium | 1 | 1991 | 31 | 0.010 |
Why?
|
| Occult Blood | 1 | 1991 | 16 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1991 | 23 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1991 | 36 | 0.010 |
Why?
|
| Enema | 1 | 1991 | 37 | 0.010 |
Why?
|
| New York | 1 | 1991 | 69 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1991 | 156 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1979 | 2262 | 0.000 |
Why?
|
| Radiography | 1 | 1979 | 813 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1979 | 1056 | 0.000 |
Why?
|
| Pregnancy | 1 | 1979 | 2894 | 0.000 |
Why?
|